Cetya therapeutics inc
WebCetya Therapeutics, Inc. is a development stage pharmaceutical company developing histone deacetylase inhibitors structurally based on the marine natural product Largazole. Cetya has the exclusive worldwide rights to the histone deacetylase (HDAC) inhibitor platfor m and patent estate developed in the laboratory of Dr. Robert M. Williams at CSU ... WebCetya Therapeutics, Inc. 4605 VALLEY RIDGE CT Fort Collins, CO 80526-6500 United States DUNS: 078526138 HUBZone Owned: No Woman Owned: No Socially and Economically Disadvantaged: No Principal Investigator Name: ROBERT WILLIAMS Phone: (970) 491-6747 Email: [email protected] Business Contact Name: CLIFFORD …
Cetya therapeutics inc
Did you know?
WebCetya Therapeutics, Inc. Website Get a D&B Hoovers Free Trial Overview Company Description:? Key Principal:Clifford Hendrick See more contacts Industry:Drugs and Druggists' Sundries Merchant Wholesalers , WebCerebral Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for refractory neurological diseases. Cetya Therapeutics: Fort Collins : Small Molecules, Therapeutics: Cetya Therapeutics, Inc. is working to develop histone deacetylase inhibitors (HDACi) based on analogs of largazole.
WebFeb 13, 2024 · Cetya Therapeutics Inc. To gain access to more vendor profiles available with Technavio, buy the report! Regional analysis. Based on region, the global HDAC (histone deacetylase) inhibitors market ... WebJul 1, 2024 · Cetya Therapeutics, Inc. is a development stage pharmaceutical company developing histone deacetylase inhibitors structurally based on the marine natural product Largazole. Cetya has …
WebJun 21, 2024 · About Cetya Therapeutics Cetya is a Fort Collins, Colorado drug development company advancing its lead compound, CT-101, for treatment of sickle cell disease. WebSep 23, 2024 · Cetya is seeking corporate partners to assist in the advancement of its analog portfolio in a number of different therapeutic indications. For more information on Cetya, please visit our website at …
WebViridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian's most advanced program ...
WebDr. Junker has worked for 30 years developing and commercializing therapeutic products for Biotechnology and Pharmaceutical companies. He served as an advisor to Cetya in 2013, VP Preclinical Development … org chart pfizerhow to use tarnxWebMr. Hendrick has been with Cetya for 8 years, serving as an advisor to Cetya for one year prior to becoming its CEO and Board member in July 2014. Prior to Cetya, Mr. Hendrick spent over 20 years working for Genzyme Corporation, most recently as the Vice President and General Manager of Early Development for the Oncology business. how to use tarot baby vapeWebSep 1, 2024 · Cetya Therapeutics General Information. Description. Developer of histone deacetylase inhibitors intended to target specific cell types or tumors. The company's inhibitors hold exclusive license rights to the Largazole analog intellectual property that is being developed to treat hemoglobinopathies and solid tumors such as autoimmune … org chart power appsWebJun 21, 2024 · About Cetya Therapeutics. Cetya is a Fort Collins, Colorado drug development company advancing its lead compound, CT-101, for treatment of sickle cell … how to use tarot cards beginnersWebdisease mouse model. Cetya will scale the CT-101 manufacturing process and produce sufficient quantities to support the murine studies and oral formulation development. The goal of this project is to develop the new high-potency HDAC inhibitor CT-101 for an IND and clinical therapeutics. To test our hypothesis the following aims will be ... how to use tarot cards in phasmophobiaWebCetya Therapeutics, Inc. (“Cetya”) was formed in 2012 to commercialize histone deacetylase inhibitors (HDACi) based on largazole. Some of these analogs have bifunctional modifications and the potential to target specific cell types or tumors. This is unique in the HDACi space and, together with potency and selectivity, differentiates Cetya ... org chart pocs_all clusters.xlsx